Pharma Journalist -

Chai Discovery has entered into a licensing agreement with pharmaceutical giant Pfizer, marking a significant step in the growing adoption of artificial intelligence technologies across…
Read More...

Cellares and TScan Therapeutics have entered into a strategic agreement to evaluate automated clinical manufacturing of TSC-101, an investigational T cell receptor-engineered T cell…
Read More...

Massive Bio and Optellum have announced a strategic collaboration designed to connect early lung cancer detection with faster access to clinical trials, potentially addressing one of…
Read More...

Roche has moved a step closer to bringing a potential new treatment option to patients with early-stage breast cancer after the U.S. Food and Drug Administration (FDA) accepted the…
Read More...

AbbVie has secured a significant regulatory milestone in Europe after the European Commission approved AQUIPTA® (atogepant) for the acute treatment of migraine in adults, providing…
Read More...

Contraline, a clinical-stage biopharmaceutical company focused on developing innovative male contraceptives, has secured $92.5 million in Series B financing to advance the late-stage…
Read More...

CytomX Therapeutics has expanded its collaboration and licensing agreement with Regeneron Pharmaceuticals to advance the development of next-generation bispecific cancer therapies,…
Read More...

Travere Therapeutics has significantly expanded its rare kidney disease pipeline through an exclusive licensing and collaboration agreement with Everest Medicines for civorebrutinib, an…
Read More...

SystImmune and Bristol Myers Squibb have reported positive Phase 3 results for izalontamab brengitecan (iza-bren), an investigational bispecific antibody-drug conjugate (ADC),…
Read More...

Vertex Pharmaceuticals has moved a step closer to bringing a new treatment option to patients with immunoglobulin A nephropathy (IgAN) after the U.S. Food and Drug Administration (FDA)…
Read More...